Simvastatin is a commonly used drug to control hypercholesterolemia to prevent cardiovascular disease, and as such epidemiological studies have shown significantly lower serum PSA, tumor volume, and percentage of cancer in radical prostatectomy samples in PCa patients on preoperative statins compared to non-users [28,29]. The gene discussed is KLK3; the disease is posterior cortical atrophy.